A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.
Placental malaria caused by Plasmodium falciparum is a major cause of mortality and severe morbidity. Clinical testing of a soluble protein-based vaccine containing the parasite ligand, VAR2CSA, has been initiated. VAR2CSA binds to the human receptor chondroitin sulphate A (CSA) and is responsible f...
Main Authors: | Susan Thrane, Christoph M Janitzek, Mette Ø Agerbæk, Sisse B Ditlev, Mafalda Resende, Morten A Nielsen, Thor G Theander, Ali Salanti, Adam F Sander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4657905?pdf=render |
Similar Items
-
Identification of glycosaminoglycan binding regions in the <it>Plasmodium falciparum </it>encoded placental sequestration ligand, VAR2CSA
by: Theander Thor G, et al.
Published: (2008-06-01) -
Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
by: Vera V Pinto, et al.
Published: (2011-03-01) -
Identification and characterization of B-cell epitopes in the DBL4ε domain of VAR2CSA.
by: Sisse B Ditlev, et al.
Published: (2012-01-01) -
Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA.
by: Pernille Andersen, et al.
Published: (2008-02-01) -
Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA.
by: Sisse B Ditlev, et al.
Published: (2014-01-01)